Table 1. ASC cohort characteristics at time of biopsy and treatment/outcome data.
The deceased donor controls (n = 17) came from age 4–17 years deceased kidney donors with females/males = 12/5 similar to the ASC patient set (14/7).
| Patient characteristics | Number | Qualifiers |
|---|---|---|
| ASC patients | 21 | |
| Clinical characteristics | ||
| Age at time of biopsy | 9.2±4.8 | Range 2–17 years |
| Females/Males | 14/7 | |
| Electron microscopic appearance | ||
| Classical Alport Syndrome pathology | 16 | 20 biopsies |
| Thin GBM | 5 | 6 biopsies |
| Clinical Outcome | ||
| Did not progress to ESKD | 14 | 14 biopsies |
| Progressed to ESKD requiring RRT | 7 | 12 biopsies |
| Treatment | ||
| ACE inhibitor | 16 |